These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review. Simmons BB; Yeo A; Fung K; ; Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455 [TBL] [Abstract][Full Text] [Related]
4. New insights in antiplatelet therapy for patients with ischemic stroke. Chaturvedi S; Bhattacharya P Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467 [TBL] [Abstract][Full Text] [Related]
5. Newer antiplatelet therapies in stroke prevention. Davis SM; Donnan GA Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112 [TBL] [Abstract][Full Text] [Related]
6. Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke. Lutsep H Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1295-303. PubMed ID: 21985542 [TBL] [Abstract][Full Text] [Related]
7. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Diener HC; Sacco R; Yusuf S; ; Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887 [TBL] [Abstract][Full Text] [Related]
8. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Diener HC Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®). Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
11. Stroke and atherothrombosis: an update on the role of antiplatelet therapy. Alexandrov AV; Alagona P Int J Stroke; 2008 Aug; 3(3):175-81. PubMed ID: 18705896 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice? Aw D; Sharma JC Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248 [TBL] [Abstract][Full Text] [Related]
14. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
15. Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events. Guthrie R Adv Ther; 2011 Jun; 28(6):473-82. PubMed ID: 21547541 [TBL] [Abstract][Full Text] [Related]
17. Antiplatelet agents for stroke prevention following transient ischemic attack. Weinberger J South Med J; 2008 Jan; 101(1):70-8. PubMed ID: 18176296 [TBL] [Abstract][Full Text] [Related]
18. Front-loading with clopidogrel plus aspirin followed by dual antiplatelet therapy in the prevention of early stroke recurrence. Censori B Expert Rev Neurother; 2014 Jul; 14(7):723-34. PubMed ID: 24881887 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153 [TBL] [Abstract][Full Text] [Related]
20. Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study. Weimar C; Cotton D; Sha N; Sacco RL; Bath PM; Weber R; Diener HC Cerebrovasc Dis; 2013; 35(6):538-43. PubMed ID: 23816610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]